US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 0.829
  • -0.009-1.09%
Close Jul 26 16:00 ET
  • 0.829
  • 0.0000.00%
Post 20:01 ET
35.40MMarket Cap-518P/E (TTM)

Achilles Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Achilles Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.30

+31.82%
Analyst Rating

No Data

Achilles Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Achilles Therapeutics Earnings Reports

  • Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 8 07:48 ET

  • Achilles Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 4 08:15 ET

  • Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 13, 2023 16:36 ET

  • Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 4, 2023 07:42 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg